The Journal of Organic Chemistry
Article
2-Propylquinoxaline (4m). Purified by analytical TLC on silica gel
with DCM/EA (50:1) as an eluent Rf = 0.74; yellow liquid (48.2 mg,
55%). H NMR (400 MHz, CDCl3): δ 8.75 (s, 1H), 8.09−8.03 (m,
2H), 7.77−7.69 (m, 2H), 3.00 (t, J = 7.7 Hz, 2H), 1.94−1.83 (m, 2H),
1.05 (t, J = 7.4 Hz, 3H). 13C{H} NMR (101 MHz, CDCl3): δ 157.5,
145.9, 142.2, 141.2, 129.9, 129.2, 128.91, 128.88, 38.4, 22.8, 13.9.
HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C11H13N2, 173.1073;
found, 173.1075.
2-Butylquinoxaline (4n). Purified by analytical TLC on silica gel
with PE/EA (10:1) as an eluent Rf = 0.44; yellow liquid (75.6 mg, 81%).
1H NMR (400 MHz, CDCl3): δ 8.73 (s, 1H), 8.07−8.02 (m, 2H),
7.74−7.66 (m, 2H), 3.00 (t, J = 7.8 Hz, 2H), 1.86−1.79 (m, 2H), 1.50−
1.40 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). 13C{H} NMR (151 MHz,
CDCl3): δ 157.7, 145.8, 142.2, 141.2, 129.9, 129.2, 128.9, 36.2, 31.6,
22.6, 13.9. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C12H15N2,
187.1230; found, 187.1231.
2-Hexylquinoxaline (4o). Purified by analytical TLC on silica gel
with PE/EA (10:1) as an eluent Rf = 0.48; yellow liquid (87.8 mg, 82%).
1H NMR (400 MHz, CDCl3): δ 8.73 (s, 1H), 8.08−8.02 (m, 2H),
7.75−7.67 (m, 2H), 3.00 (t, J = 7.7 Hz, 2H), 1.88−1.80 (m, 2H), 1.44−
1.39 (m, 2H), 1.37−1.28 (m, 4H), 1.88 (t, J = 7.2 Hz, 3H). 13C{H}
NMR (151 MHz, CDCl3): δ 157.7, 145.8, 142.2, 141.2, 129.9, 129.2,
128.9, 36.5, 31.6, 29.5, 22.5, 14.0. HRMS (ESI+, MeOH) m/z: [M +
H]+ calcd for C14H19N2, 215.1543; found, 215.1546.
7.85 (d, J = 8.4 Hz, 1H), 7.73 (s, 1H), 7.49 (d, J = 8.4 Hz, 1H), 3.14 (m,
4H), 2.56 (s, 3H), 2.03 (m, 4H). 13C{H} NMR (151 MHz, CDCl3): δ
154.0, 153.1, 141.3, 139.7, 139.2, 131.2, 127.9, 127.3, 33.2, 33.1, 22.88,
22.87, 21.8. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C13H15N2,
199.1230; found, 199.1232.
1
7-Chloro-1,2,3,4-tetrahydrophenazine (4v). Purified by analytical
TLC on silica gel with DCM/EA (50:1) as an eluent Rf = 0.50; brown
solid (63.6 mg, 58% yield from 4-chloro-2-nitroaniline; 75.0 mg, 69%
1
yield from 5-chloro-2-nitroaniline). mp: 91−92 °C. H NMR (600
MHz, CDCl3): δ 7.96 (s, 1H), 7.89 (d, J = 8.7 Hz, 1H), 7.60 (d, J = 8.7
Hz, 1H), 3.15 (m, 4H), 2.04 (m, 4H). 13C{H} NMR (151 MHz,
CDCl3): δ 155.3, 154.5, 141.5, 139.7, 134.5, 129.9, 129.6, 127.4, 33.21,
33.16, 22.70, 22.68. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for
C12H12ClN2, 219.0684; found, 219.0683.
7,8-Dimethyl-1,2,3,4-tetrahydrophenazine (4w). Purified by ana-
lytical TLC on silica gel with DCM/EA (50:1) as an eluent Rf = 0.40;
yellow solid (74.2 mg, 70%). mp: 143−145 °C. 1H NMR (600 MHz,
CDCl3): δ 7.70 (s, 2H), 3.13 (m, 4H), 2.46 (s, 6H), 2.02 (m, 4H).
13C{H} NMR (151 MHz, CDCl3): δ 153.0, 140.2, 139.2, 127.5, 33.1,
22.9, 20.3. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C14H17N2,
213.1386; found, 213.1386.
8-Bromo-6-methyl-1,2,3,4-tetrahydrophenazine (4x). Purified by
analytical TLC on silica gel with PE/DCM (1:1) as an eluent Rf = 0.33;
1
yellow solid (70.7 mg, 51%). mp: 63−65 °C. H NMR (400 MHz,
2-(Naphthalen-2-yl)quinoxaline (4p). Purified by analytical TLC
on silica gel with PE/EA (10:1) as an eluent Rf = 0.30; yellow solid
CDCl3): δ 7.98 (d, J = 1.8 Hz, 1H), 7.59 (d, J = 1.1 Hz, 1H), 3.15−3.12
(m, 4H), 2.73 (s, 3H), 2.05−2.01 (m, 4H). 13C{H} NMR (151 MHz,
CDCl3): δ 154.6, 153.4, 141.9, 139.3, 138.7, 132.1, 128.5, 122.2, 33.4,
33.1, 22.8, 17.0. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for
C13H14BrN2, 277.0335; found, 277.0340.
1
(20.5 mg, 80%). mp: 126−127 °C. H NMR (400 MHz, CDCl3): δ
9.48 (s, 1H), 8.66 (s, 1H), 8.36 (dd, J = 8.6, 1.8 Hz, 1H), 8.21−8.19 (m,
1H), 8.16−8.13 (m, 1H), 8.04−8.00 (m, 2H), 7.92−7.90 (m, 1H),
7.83−7.73 (m, 2H), 7.59−7.54 (m, 2H). 13C{H} NMR (101 MHz,
CDCl3): δ 151.7, 143.5, 142.4, 141.6, 134.2, 134.1, 133.4, 130.4, 129.7,
129.6, 129.2, 129.1, 128.9, 127.8, 127.5, 127.3, 126.7, 124.5. HRMS
(ESI+, MeOH) m/z: [M + H]+ calcd for C18H13N2, 257.1073; found,
257.1076.
6,7-Dimethyl-2-phenylquinoxaline (4y). Purified by analytical TLC
on silica gel with DCM/EA (50:1) as an eluent Rf = 0.64; white solid
1
(93.5 mg, 80%). mp: 128−130 °C. H NMR (400 MHz, CDCl3): δ
9.22 (s, 1H), 8.18−8.16 (m, 2H), 7.91 (s, 1H), 7.86 (s, 1H), 7.58−7.48
(m, 3H), 2.51 (s, 6H). 13C{H} NMR (151 MHz, CDCl3): δ 151.0,
142.4, 141.3, 140.8, 140.6, 140.1, 137.2, 129.8, 129.1, 128.7, 128.2,
127.4, 20.4, 20.3. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for
C16H15N2, 235.1230; found, 235.1230.
6-Methyl-2,3-diphenylquinoxaline (4q). Purified by analytical TLC
on silica gel with PE/DCM (1:1) as an eluent Rf = 0.48; white solid
(136.6 mg, 92%). mp: 111−112 °C. 1H NMR (400 MHz, CDCl3): δ
8.06 (d, J = 8.5 Hz, 1H), 7.95 (s, 1H), 7.61(dd, J = 8.6, 1.8 Hz, 1H),
7.52−7.49 (m, 4H), 7.36−7.30 (m, 6H), 2.62 (s, 3H). 13C{H} NMR
(101 MHz, CDCl3): δ 153.3, 152.6, 141.3, 140.5, 139.7, 139.2, 132.3,
129.9, 129.8, 128.73, 128.70, 128.6, 128.2, 128.0, 21.9. HRMS (ESI+,
MeOH) m/z: [M + H]+ calcd for C21H17N2, 297.1387; found,
297.1387.
6-Chloro-2,3-diphenylquinoxaline (4r). Purified by analytical TLC
on silica gel with PE/DCM (2:1) as an eluent Rf = 0.18; white solid
(145.7 mg, 92% yield from 4-chloro-2-nitroaniline; 153.6 mg, 97% yield
from 5-chloro-2-nitroaniline). mp: 110−111 °C. 1H NMR (400 MHz,
CDCl3): δ 8.15 (d, J = 2.2 Hz, 1H), 8.08 (d, J = 9.2 Hz, 1H), 7.68 (dd, J
= 8.9, 2.3 Hz, 1H), 7.51−7.49 (m, 4H), 7.38−7.30 (m, 6H). 13C{H}
NMR (101 MHz, CDCl3): δ 154.3, 153.6, 141.5, 139.7, 138.8, 138.7,
135.7, 131.0, 130.5, 129.9, 129.8, 129.1, 129.0, 128.35, 128.34, 128.1.
HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C20H14ClN2,
317.0840; found, 317.0840.
6,7-Dimethyl-2,3-diphenylquinoxaline (4s). Purified by analytical
TLC on silica gel with PE/DCM (1:1) as an eluent Rf = 0.38; white
solid (152.0 mg, 98%). mp: 176−177 °C. 1H NMR (400 MHz,
CDCl3): δ 7.92 (s, 2H), 7.51−7.49 (m, 4H), 7.35−7.29 (m, 6H), 2.52
(s, 6H). 13C{H} NMR (101 MHz, CDCl3): δ 152.5, 140.5, 140.2,
139.4, 129.9, 128.5, 128.23, 128.20, 20.4. HRMS (ESI+, MeOH) m/z:
[M + H]+ calcd for C22H19N2, 311.1543; found, 311.1541.
6,7-Dichloro-2,3-diphenylquinoxaline (4t). Purified by analytical
TLC on silica gel with PE/DCM (2:1) as an eluent Rf = 0.28; white
solid (140.2 mg, 80%). mp: 138−139 °C. 1H NMR (600 MHz,
CDCl3): δ 8.29 (s, 2H), 7.50 (d, J = 7.5 Hz, 4H), 7.40−7.33 (m, 6H).
13C{H} NMR (101 MHz, CDCl3): δ 154.5, 140.0, 138.4, 134.4, 129.8,
129.3, 128.4. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for
C20H13Cl2N2, 351.0450; found, 351.0452.
6,7-Dichloro-2-phenylquinoxaline (4z). Purified by analytical TLC
on silica gel with PE/EA (15:1) as an eluent Rf = 0.53; yellow solid
1
(63.0 mg, 46%). mp: 155−157 °C. H NMR (400 MHz, CDCl3): δ
9.32 (s, 1H), 8.28 (s, 1H), 8.24 (s, 1H), 8.20−8.18 (m, 2H), 7.61−7.55
(m, 3H). 13C{H} NMR (101 MHz, CDCl3): δ 152.7, 144.3, 141.1,
140.3, 136.0, 134.9, 134.0, 130.9, 130.2, 129.8, 129.3, 127.6. HRMS
(ESI+, MeOH) m/z: [M + H]+ calcd for C14H9Cl2N2, 275.0137; found,
275.0142.
2,3-Bis(4-methoxyphenyl)quinoxaline (4aa). Purified by analytical
TLC on silica gel with PE/DCM (1:3) as an eluent Rf = 0.21; yellow
solid (34.0 mg, 99% yield from o-nitroanilines; 89.2 mg, 52% yield from
1
1,2-dinitrobenzene). mp: 143 °C. H NMR (400 MHz, CDCl3): δ
8.14−8.10 (m, 2H), 7.73−7.69 (m, 2H), 7.51−7.48 (m, 4H), 6.89−
6.85 (m, 4H), 3.82 (s, 6H). 13C{H} NMR (101 MHz, CDCl3): δ 160.2,
153.0, 141.1, 131.8, 131.3, 129.5, 129.0, 113.8, 55.3. HRMS (ESI+,
MeOH) m/z: [M + H]+ calcd for C22H19N2O2, 343.1441; found,
343.1444.
2,3-Di(furan-2-yl)quinoxaline (4ab). Purified by analytical TLC on
silica gel with PE/DCM (1:3) as an eluent Rf = 0.42; brown solid (25.9
1
mg, 99%). mp: 122−123 °C. H NMR (400 MHz, CDCl3): δ 8.16−
8.12 (m, 2H), 7.77−7.32 (m, 2H), 7.63 (dd, J = 1.7, 0.67 Hz, 2H), 6.66
(dd, J = 3.5, 0.52 Hz, 2H), 6.57 (dd, J = 3.5, 1.7 Hz, 2H). 13C{H} NMR
(101 MHz, CDCl3): δ 150.8, 144.2, 142.7, 140.6, 130.4, 129.1, 113.0,
111.9. HRMS (ESI+, MeOH) m/z: [M + H]+ calcd for C16H11N2O2,
263.0815; found, 263.0818.
2,3-Bis(4-methoxyphenyl)-6-methylquinoxaline (4ac). Purified by
analytical TLC on silica gel with PE/DCM (1:3) as an eluent Rf = 0.23;
yellow solid (31.6 mg, 88%). mp: 118−119 °C. 1H NMR (400 MHz,
CDCl3): δ 8.01 (d, J = 8.5 Hz, 1H), 7.90 (s, 1H), 7.55 (dd, J = 6.8, 1.8
Hz, 1H), 7.50−7.46 (m, 4H), 6.88−6.85 (m, 4H), 3.82 (s, 6H), 2.59 (s,
3H). 13C{H} NMR (101 MHz, CDCl3): δ 160.1, 160.0, 152.9, 152.2,
141.1, 140.0, 139.5, 131.91, 131.86, 131.2, 128.5, 127.9, 113.8, 113.7,
7-Methyl-1,2,3,4-tetrahydrophenazine (4u). Purified by analytical
TLC on silica gel with DCM/EA (50:1) as an eluent Rf = 0.35; yellow
solid (79.2 mg, 80%). mp: 80−81 °C. 1H NMR (600 MHz, CDCl3): δ
H
J. Org. Chem. XXXX, XXX, XXX−XXX